Table 2.
Biomaterials | Cell types | 2D/3D | Feeder layer | Conditioned medium | Undifferentiated cells can be maintained | References | |
---|---|---|---|---|---|---|---|
Natural | Matrigel, vitronectin | Human ESCs and human iPSCs | 2D | No | No | 25 passages | 77 |
Matrigel, a combination of collagen IV, fibronectin, laminin, and vitronectin | Human ESCs | 2D | No | No | 20 passages | 57 | |
Matrigel | Human ESCs | 2D | No | No | 9 and 22 passages | 78 | |
Matrigel, Collagen IV | Human ESCs | 2D | No | Yes | 130 population doublings | 76 | |
Collagen I | Human ESCs | 2D | No | Yes | 7 passages | 80 | |
Laminin-111, -332 and -511 | Human ESCs | 2D | No | Yes | 10 passages | 82 | |
Laminin-511 | Murine ESCs | 2D | No | No | 31 passages | 84 | |
Human ESCs and iPSCs | 2D | No | No | 20 passages | 85 | ||
Vitronectin | Human ESCs | 2D | No | No | 7 passages | 87 | |
Human iPSCs | 2D | No | No | 10 passages | 90 | ||
Calcium alginate hydrogels | Human ESCs | 3D | No | No | 260 days without passaging in the undifferentiated stage | 112 | |
Synthetic | PAS | Human ESCs | 2D | No | No | 10 passages | 93 |
Heparin-binding peptides | Human ESCs | 2D | No | No | 17 passages | 94 | |
APMAAm | Human ESCs | 2D | No | No | 20 passages | 97 | |
PMEDSAH | Human ESCs | 2D | No | No | 10 passages | 98 | |
sIPN | Human ESCs | 3D | No | Yes | 5 days | 104 | |
HA | Human ESCs | 3D | No | Yes | 20 days | 107 |
2D, two dimensional; 3D, three dimensional; PAS, peptide-acrylate surfaces; APMAAm, aminopropylmethacrylamide; PMEDSAH, poly[2-(methacryloyloxy)ethyl dimethyl-(3-sulfopropyl)ammonium hydroxide]; sIPN, semi-interpenetrating polymer network; HA, hyaluronic acid.